US Stock MarketDetailed Quotes
LSTA Lisata Therapeutics
- 2.840
- -0.040-1.39%
Close Nov 26 16:00 ET
23.84MMarket Cap-1131P/E (TTM)
2.950High2.780Low15.03KVolume2.950Open2.880Pre Close43.06KTurnover0.21%Turnover RatioLossP/E (Static)8.39MShares3.83052wk High0.71P/B19.99MFloat Cap2.11052wk Low--Dividend TTM7.04MShs Float1350000.000Historical High--Div YieldTTM5.90%Amplitude1.950Historical Low2.864Avg Price1Lot Size
Lisata Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 29.72%-2.52M | -26.27%-5.28M | 14.26%-7.03M | 5.38%-20.03M | 37.09%-4.07M | 10.38%-3.58M | 17.34%-4.18M | -45.27%-8.2M | 4.83%-21.17M | -40.49%-6.47M |
| Net income from continuing operations | 6.29%-4.93M | -25.25%-5.04M | 12.70%-5.4M | 61.57%-20.84M | 10.43%-5.37M | 85.93%-5.26M | 39.22%-4.03M | -46.40%-6.19M | -97.43%-54.23M | 11.83%-5.99M |
| Operating gains losses | --30K | --0 | 3,233.33%100K | --3K | --0 | --0 | --0 | --3K | ---- | ---- |
| Depreciation and amortization | -10.64%42K | -4.26%45K | -4.17%46K | 173.91%189K | 0.00%47K | 487.50%47K | 571.43%47K | 585.71%48K | 25.45%69K | 487.50%47K |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --30.39M | --0 |
| Change In working capital | 30.93%2.1M | 26.52%-388K | 19.24%-2.07M | 44.40%-462K | 215.65%1.03M | -17.63%1.61M | -165.67%-528K | 4.82%-2.57M | -228.44%-831K | -172.37%-888K |
| -Change in prepaid assets | 127.15%1.92M | 5.91%520K | 47.22%-872K | 2.49%-824K | 41.65%-510K | 9.57%847K | 118.22%491K | -70.49%-1.65M | -86.53%-845K | -217.16%-874K |
| -Change in payables and accrued expense | -81.66%137K | 1.96%-950K | -14.77%-1.24M | 139.46%88K | 2,008.22%1.39M | -33.18%747K | -287.07%-969K | 39.36%-1.08M | -117.84%-223K | -108.27%-73K |
| -Change in other current assets | 230.77%43K | 184.00%42K | -75.45%41K | 15.61%274K | 144.07%144K | -78.33%13K | -181.97%-50K | 192.98%167K | 258.00%237K | 114.68%59K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 29.72%-2.52M | -26.27%-5.28M | 14.26%-7.03M | 5.38%-20.03M | 37.09%-4.07M | 10.38%-3.58M | 17.34%-4.18M | -45.27%-8.2M | 4.83%-21.17M | -40.49%-6.47M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -151.46%-6.31M | 1,715.59%11.71M | 50.06%6.44M | -65.06%10.1M | -180.41%-5.71M | 441.88%12.25M | -102.83%-725K | 170.43%4.29M | 152.67%28.91M | -56.82%7.11M |
| Net PPE purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -375.00%-285K | ---26K |
| Net business purchase and sale | ---30K | --0 | ---100K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net investment purchase and sale | -151.22%-6.28M | 1,715.59%11.71M | 52.39%6.54M | -68.93%10.1M | -180.12%-5.71M | 378.77%12.25M | -102.02%-725K | 170.43%4.29M | 159.30%32.52M | -56.67%7.13M |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---3.32M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -151.46%-6.31M | 1,715.59%11.71M | 50.06%6.44M | -65.06%10.1M | -180.41%-5.71M | 441.88%12.25M | -102.83%-725K | 170.43%4.29M | 152.67%28.91M | -56.82%7.11M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -92.92%32K | -67.06%-142K | 271.88%385K | 71.43%24K | 93.94%-6K | 1,458.62%452K | 49.40%-85K | -100.26%-224K | -33.33%14K |
| Net common stock issuance | --0 | ---- | ---- | 646.51%321K | 71.43%24K | --0 | ---- | ---- | -99.95%43K | -33.33%14K |
| Proceeds from stock option exercised by employees | --0 | ---- | ---- | --155K | --0 | --0 | ---- | ---- | --0 | --0 |
| Net other financing activities | --0 | --0 | -67.06%-142K | 65.92%-91K | --0 | 93.94%-6K | --0 | 49.40%-85K | -7.66%-267K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | -92.92%32K | -67.06%-142K | 271.88%385K | 71.43%24K | 93.94%-6K | 1,458.62%452K | 49.40%-85K | -100.26%-224K | -33.33%14K |
| Net cash flow | ||||||||||
| Beginning cash position | 19.43%28.29M | -22.55%21.81M | -29.74%22.59M | 30.46%32.15M | 3.02%32.43M | -28.96%23.69M | 120.88%28.16M | 30.46%32.15M | 49.27%24.65M | 146.46%31.48M |
| Current changes in cash | -201.85%-8.82M | 244.99%6.46M | 81.64%-733K | -226.98%-9.55M | -1,596.78%-9.76M | 571.84%8.66M | -121.63%-4.46M | 66.45%-3.99M | -7.60%7.52M | -94.51%652K |
| Effect of exchange rate changes | -48.00%39K | 425.00%26K | -685.71%-55K | -60.00%-16K | -416.67%-76K | 320.59%75K | ---8K | ---7K | ---10K | --24K |
| End cash Position | -39.84%19.51M | 19.43%28.29M | -22.55%21.81M | -29.74%22.59M | -29.74%22.59M | 3.02%32.43M | -28.96%23.69M | 120.88%28.16M | 30.46%32.15M | 30.46%32.15M |
| Free cash flow | 29.72%-2.52M | -26.27%-5.28M | 14.26%-7.03M | 6.63%-20.03M | 37.34%-4.07M | 10.91%-3.58M | 21.01%-4.18M | -45.27%-8.2M | 3.81%-21.46M | -41.05%-6.49M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data